Hepatology
Conference Coverage
Investigational HBV core inhibitor shows early clinical promise
An investigational drug that targets the hepatitis B virus (HBV) core protein is a “totally new approach” to treating chronic HBV infection...
Conference Coverage
Biliary inflammation reduced by IBD drug
The monoclonal antibody vedolizumab may reduce biliary inflammation in patients with primary sclerosing cholangitis and comorbid inflammatory...
Conference Coverage
New hope for primary sclerosing cholangitis treatment
A modified form of ursodeoxycholic acid could offer patients with primary sclerosing cholangitis the first real pharmacologic treatment option, it...
Conference Coverage
Fibrosis still key to predicting NAFLD mortality
BARCELONA – Although a new histological scoring system was able to predict mortality from nonalcoholic fatty liver disease (NAFLD), fibrosis...
News
Study: Few HCV-infected heroin users linked to outpatient care
Despite the ease of access to hepatitis C virus screening and the availability of curative therapies, linkage to care after detection of infection...
News
Report laid groundwork for ending the public health problem of viral hepatitis
The United States can end hepatitis B and C transmission and prevent related morbidity and mortality given enough time, resources, and will to...
News
Hepatitis C virus transmission peaked in 1950
Key clinical point: Iatrogenic factors, rather than high-risk behaviors, were the most likely cause of the exponential spread of hepatitis C virus...
Conference Coverage
Three things hospitalists ‘do for no reason’... and should stop
Dr. Leonard Feldman, a hospitalist at Johns Hopkins University, Baltimore, has presented a list of usually unnecessary hospitalist practices for 5...
News
Fatty liver risk rises in years after transplant
Steatosis may be present in at least half of liver transplant recipients, and the prevalence increases significantly over time, according to data...
Conference Coverage
VIDEO: How to recognize and treat nonalcoholic fatty liver disease
News
Grim projections for hepatitis C disease burden in the U.S.
Unless screening and treatment capacity for hepatitis C virus infection are expanded, associated disease burdens are projected to remain high,...